Inspire's Q1 2026 print attributes a combined $120 to $150 million FY26 hit to WISeR plus coding uncertainty, six sell-side analysts cut targets through 7 May, and NeuroPace just received a 43% to 47% Medicare reimbursement increase on the same rule cycle.
Illinois Institute of Technology and Rush University Medical Center completed the third implantation of the Intracortical Visual Prosthesis on 7 May 2026, a 34-stimulator, 544-electrode wireless system bypassing the eye and optic nerve to deliver artificial sight directly to the visual cortex.
Humana issues the first Medicare Advantage coverage policy for CVRx's Barostim baroreflex neuromodulation therapy effective 1 May 2026, the fourth 2026 reimbursement and trial milestone for the bioelectronic heart-failure category.
Opie joins ASX-listed Australian assistive-tech company Control Bionics as Non-Executive Director and strategic advisor, with 1.25 million options vesting over four years pending shareholder approval at the 2026 AGM.
Columbia's Zuckerman Institute and collaborators at UCSF, NYU and Northwell Health published the first real-time human-study evidence that an auditory attention decoding BCI can isolate a single speaker in a multi-talker environment.
C.P. Group Innovation led Axoft's $55 million Series A on 29 April 2026. One day earlier, C.P. Group subsidiary True Corporation announced a clinical pilot partnership with Shanghai-based OYMotion. The Thai conglomerate is now operating across both Western and Chinese BCI capability through different mechanisms.
The State Council's biomedical-new-technologies regulation took effect 1 May 2026, letting Chinese hospitals charge for BCI commercially after a translation approval. Foreign-invested enterprises remain locked out.
Oman Investment Authority's Neuralink position is the latest entry in a sovereign-capital and tech-billionaire cohort racing into brain-computer interfaces.
The Senate passed H.814 in concurrence with the House on 6 May. What now sits with Governor Scott is a 6-page recognition statute, with the enforcement layer stripped in committee.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. One-click unsubscribe. We respect your privacy.